Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Edaravone in Iranian ALS Patients
NCT03272802Phase 3Unknown
- Start
- Mar 2017
- Primary completion
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of edaravone in amyotrophic lateral sclerosis (ALS). Status: unknown.
02
Drugs
edaravone
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on NCT03272802.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03272802.